T cell responses to SARS-CoV-2 in humans and animals

Sameer-ul-Salam Mattoo; Jinjong Myoung

doi:10.1007/s12275-022-1624-z

Articles

Page Path: HOME > J. Microbiol > Volume 60(3); 2022 > Article

Review
T cell responses to SARS-CoV-2 in humans and animals: Sameer-ul-Salam Mattoo , Jinjong Myoung; Journal of Microbiology 2022;60(3):276-289.
DOI: https://doi.org/10.1007/s12275-022-1624-z
Published online: February 14, 2022

Korea Zoonosis Research Institute, Department of Bioactive Material Science and Genetic Engineering Research Institute, Jeonbuk National University, Jeonju 54531, Republic of Korea

Corresponding author: Jinjong Myoung , Tel: +82-63-9004055,

Received: 1 December 2021 • Revised: 28 December 2021 • Accepted: 28 December 2021

prev next

134 Views
0 Download
10 Web of Science
10 Crossref
10 Scopus

Full Article

Abstract

SARS-CoV-2, the causative agent of COVID-19, first emerged in 2019. Antibody responses against SARS-CoV-2 have been given a lot of attention. However, the armamentarium of humoral and T cells may have differing roles in different viral infections. Though the exact role of T cells in COVID-19 remains to be elucidated, prior experience with human coronavirus has revealed an essential role of T cells in the outcomes of viral infections. Moreover, an increasing body of evidence suggests that T cells might be effective against SARS-CoV-2. This review summarizes the role of T cells in mouse CoV, human pathogenic respiratory CoV in general and SARSCoV- 2 in specific.

Keywords: SARS-CoV-2, T cell, coronavirus, immune response

Figure & Data

References

Citations

Citations to this article as recorded by

Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, Shin-Ru Shih
Vaccines.2024; 12(12): 1345. CrossRef
Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study
Ratchanon Sophonmanee, Perawas Preampruchcha, Jomkwan Ongarj, Bunya Seeyankem, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
Vaccines.2024; 12(2): 109. CrossRef
Safety and efficacy of COVID-19 vaccine immunization during pregnancy in 1024 pregnant women infected with the SARS-CoV-2 Omicron virus in Shanghai, China
Hongmei Deng, Yinpeng Jin, Minmin Sheng, Min Liu, Jie Shen, Wei Qian, Gang Zou, Yixin Liao, Tiefu Liu, Yun Ling, Xiaohong Fan
Frontiers in Immunology.2024;[Epub] CrossRef
Differential Impact of Spike Protein Mutations on SARS-CoV-2 Infectivity and Immune Evasion: Insights from Delta and Kappa Variants
Tae-Hun Kim, Sojung Bae, Jinjong Myoung
Journal of Microbiology and Biotechnology.2024; 34(12): 2506. CrossRef
Animal models for COVID-19 and tuberculosis
Björn Corleis, Max Bastian, Donata Hoffmann, Martin Beer, Anca Dorhoi
Frontiers in Immunology.2023;[Epub] CrossRef
A mathematical model and simulation scenarios for T and B cells immune response to severe acute respiratory syndrome-coronavirus-2
L Cuesta-Herrera, F Córdova-Lepe, L Pastenes, A D Arencibia, Y Baldera-Moreno, H A Torres-Mantilla
Journal of Physics: Conference Series.2023; 2516(1): 012007. CrossRef
Distinctive Combinations of RBD Mutations Contribute to Antibody Evasion in the Case of the SARS-CoV-2 Beta Variant
Tae-Hun Kim, Sojung Bae, Sunggeun Goo, Jinjong Myoung
Journal of Microbiology and Biotechnology.2023; 33(12): 1587. CrossRef
Two years of COVID-19 pandemic: where are we now?
Jinjong Myoung
Journal of Microbiology.2022; 60(3): 235. CrossRef
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin
Sameer-ul-Salam Mattoo, Seong-Jun Kim, Dae-Gyun Ahn, Jinjong Myoung
Viruses.2022; 14(3): 530. CrossRef
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
Irina Isakova-Sivak, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria Mezhenskaya, Ekaterina Bazhenova, Elena Krutikova, Tatiana Kotomina, Polina Prokopenko, Bogdan Neterebskii, Aleksandr Doronin, Elena Vinogradova, Kirill Yakovlev, Konst
Vaccines.2022; 10(7): 1142. CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

T cell responses to SARS-CoV-2 in humans and animals

J. Microbiol. 2022;60(3):276-289. Published online February 14, 2022

DOI: https://doi.org/10.1007/s12275-022-1624-z

Related articles